Skip to main content
Katharine Nicholson, MD, Neurology, Boston, MA, Massachusetts General Hospital

KatharineAmesNicholsonMD

Neurology Boston, MA

Neuromuscular Medicine

Physician

Dr. Nicholson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nicholson's full profile

Already have an account?

  • Office

    165 Cambridge St Ste 600
    Neurological Clinical Research Institute, Massachusetts General Hospital
    Boston, MA 02114
  • Is this information wrong?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Clinical Research Fellowship in Neurodegenerative Disorders, focus on ALS, 2014 - 2015
  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Neuromuscular Medicine (Neurology), 2013 - 2014
  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Neurology, 2010 - 2013
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 2009

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2013 - 2026
  • RI State Medical License
    RI State Medical License 2022 - 2024
  • NH State Medical License
    NH State Medical License 2022 - 2024
  • ME State Medical License
    ME State Medical License 2021 - 2024
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Neuromuscular Medicine

Publications & Presentations

PubMed

Press Mentions

  • Dosing Begins in Phase 2 Trial of AL001 in ALS with C9orf72 Mutations
    Dosing Begins in Phase 2 Trial of AL001 in ALS with C9orf72 MutationsSeptember 13th, 2021
  • The Human Gut Microbiota in People with Amyotrophic Lateral Sclerosis
    The Human Gut Microbiota in People with Amyotrophic Lateral SclerosisJune 15th, 2020

Hospital Affiliations